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Abstract In this study, we evaluated a fourth-generation
agglutination assay (Staph Plus; DiaMondiaL[DML]) for
the rapid identification of Staphylococcus aureus. First,
comparison with three third-generation assays (Slidex
Staph Plus, bioMérieux; Staphaurex Plus, Murex Diagnos-
tics; Pastorex Staph-Plus, Sanofi Diagnostics Pasteur)
was performed on a predefined strain collection: 265
coagulase-negative staphylococci (CNS), 266 methicillin-
resistant S. aureus (MRSA) and 262 methicillin-susceptible
S. aureus (MSSA) strains (“strain study”). Second, patient
material-derived strains (883 CNS, 847 MSSA and 135
MRSA) were tested concurrently with both the DML and
Slidex assays (“daily practice study”). In the strain study,
the overall sensitivity and specificity of the DML, Slidex,
Staphaurex and Pastorex assays were 99.2% and 100%,
98.1% and 100%, 95.2% and 100%, and 98.2% and 98.8%,
respectively. Using the respective tests, the result was
indeterminate in 0.0%, 0.6%, 0.4% and 1.5% of the strains.
Overall, the sensitivity of the DML and Slidex assays were
comparable in both sub-studies. However, in MRSA
strains, the sensitivity of the DML assay was significantly
lower than the Slidex assay. The specificity of the Slidex
assay was significantly higher than the DML assay.
However, the percentage of indeterminate results was much
higher for the Slidex than the DML assay. In conclusion,
the presumptive identification of S. aureus by the DML
assay proved to be equal to third-generation latex aggluti-
nation assays.
Introduction
Infections with Staphylococcus aureus are common, both
inside and outside the hospital, and can have serious
medical consequences if not diagnosed in a timely manner.
Therefore, in clinical microbiology laboratories, quick and
reliable identification of S. aureus is a major quality
characteristic. Differentiating S. aureus from other staphy-
lococci has traditionally been done using a coagulase tube
test. Although this test is reliable, it takes up to 24 h to
provide results. Since the late 1970s, several alternative
procedures have been developed with variable success. In
1980, the first latex agglutination assay with accurate
identification of S. aureus was introduced by Essers and
Radebold [1]. This assay is based on the detection of both
coagulase activity (clumping factor) and protein A, both
being specific determinants of S. aureus. In the last 30 years,
several commercial assays based on this principle have
been launched. However, certain methicillin-resistant S.
aureus (MRSA) strains produced false-negative results in
some agglutination assays. In an attempt to overcome this
problem, third-generation latex agglutination assays have
been developed that also detect capsular polysaccharides 5
and 8, specific antigens present on the surface of up to 80%
of S. aureus strains [2]. In effect, the detection of capsular
polysaccharides 5 and 8 has been demonstrated to improve
the detection of MRSA strains [3].
Recently, the Staph Plus Latex Kit (DiaMondiaL [DML],
Sees, France), a new latex agglutination assay for the
identification of S. aureus, has been marketed. In order to
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hence, false-negative test results, in this fourth-generation
assay, newly developed blue carboxylated microparticles
were used in combination with the detection of coagulase,
protein A and capsular polysaccharides 5 and 8.
In this study, we compared the performance of the Staph
Plus Latex Kit to three third-generation latex assays (a) on a
well-defined collection of staphylococci and (b) in daily
practice in a routine microbiology laboratory.
Materials and methods
In order to analyse both agglutination performance on
different individual strains and staphylococcal sub-types
versus practical assay performance during daily routine, the
evaluation of the DiaMondiaL Staph Plus Latex Kit™
(DML Staph) was performed in two separate sub-studies:
(a) evaluation of the DML Staph performance on a
predefined staphylococcal strain collection (“strain study”),
comparing DML Staph results to historical data of three
third-generation latex agglutination assays, and (b) com-
paring DML Staph with Slidex Staph Plus on consecutive
clinical staphylococcal strains in a routine microbiology
laboratory (“daily practice study”).
Strain study
The collection of staphylococcal strains used in the strain
study was derived from two previously published studies
by van Griethuysen et al. [4, 5]. From these studies,
historical data were available on the performance of three
third-generation latex agglutination assays: (1.) Slidex
Staph Plus (bioMérieux), (2.) Staphaurex Plus (Murex
Diagnostics) and (3.) Pastorex Staph-Plus (Sanofi Diag-
nostics Pasteur). In total, 265 coagulase-negative staphylo-
cocci (CNS) and 528 S. aureus strains (266 methicillin-
resistant S. aureus [MRSA] and 262 methicillin-susceptible
S. aureus [MSSA]) were conserved and available for use in
this study. All isolates were derived from human clinical
isolates. Amongst the CNS strains, a wide variety of sub-
species were available (Table 1).
All strains were defined in the van Griethuysen et al.
studies by the same principle [4, 5]: if the tube coagulase
test and all three of the above-mentioned latex agglutination
tests were positive, the isolate was considered to be S.
aureus. If all tests were negative, the isolate was considered
to be a CNS and further identification to the species level
was determined with the ID32 Staph System (bioMérieux).
If the results of the tube coagulase test and the latex
agglutination tests were discordant, these tests were
repeated from a new sub-culture and an ID32 Staph test,
and either an AccuProbe culture identification test in one
study [5] (Gen-Probe, San Diego, CA, USA) or coagulase
gene polymerase chain reaction (PCR) in the other study [4]
(see further for specifications) were performed. The result
of either the AccuProbe or coagulase gene PCR was
considered to be the gold standard. MRSA strains were
defined by the presence of the mecA gene and the coagulase
gene by multiplex PCR [4, 5].
The collection of strains was stored at −70°C since the
year 2000. Shortly before testing, all isolates were sub-
cultured from the −70°C freezer onto Columbia agar +5%
sheep blood (BioTrading, Mijdrecht, The Netherlands).
Subsequently, all strains were sub-cultured one more time
on the same media to obtain fresh growth.
The freshly cultured strains were tested using the DML
Staph according to the manufacturer’s instructions in a
random fashion; the performing laboratory physician was
not aware of the strain type during testing. The assay
consists of a negative control reagent and a test reagent
containing blue carboxylated microparticles sensitised with
human fibrinogen and monoclonal antibodies for the
simultaneous detection of coagulase activity, staphylococ-
cal protein A and capsular polysaccharides 5 and 8. Every
strain was tested using a negative control latex reagent to
exclude non-specific agglutination. A test was considered
to be positive if there was visible agglutination and clearing
of the background and no agglutination in the control
reagent. One person performed all tests on ten separate days
during a 3-week period and the results were recorded on a
spreadsheet (Excel).
All isolates with discordant test results of the DML
Staph assay were retested for deoxyribonuclease (DNAse)
activity (in-house product) [6], coagulase activity (Coagu-
Table 1 Number of different staphylococcal sub-species among the
coagulase-negative strains
Staphylococcal species No. tested
S. epidermidis 136
S. hominis 36
S. lugdunensis 24
S. capitis 20
S. warneri 8
S. xylosus 5
S. haemolyticus 5
S. saprophyticus 4
S. simulans 2
S. sciuri 2
S. caprae 2
S. cohnii 3
S. auricularis 1
CNS undetermined 17
Total 265
260 Eur J Clin Microbiol Infect Dis (2011) 30:259–264lase Plasma Rabbit, Becton Dickinson, Bedford, MA,
USA), the presence of the mecA gene and S. aureus-
specific genomic DNA (PCR) to confirm identification of
the specific strain. The mecA/S. aureus-PCR was developed
in-house and consisted of simultaneous detection (Light-
Cycler 2.0, Roche) of the mecA gene [7] and S. aureus-
specific genomic DNA [8]. The primers and probes were
designed as follows: mecA gene (forward primer 5′-GAT-
CGC-AAC-GGT-CAA-TTT-AAT-TTT-G-3′, reverse primer
3′-GCT-TTG-GTC-TTT-CTG-CAT-TCC-T-5′ and fluores-
cent [FAM] TaqMan probe FAM-GGT-ATG-TGG-AAG-
TTA-GAT-TGG-GAT-CAT-AGC-GTC-BHQ1) and S. aure-
us-specific genomic DNA (forward primer 5′-CAT-CGG-
AAA-CAT-TGT-GTT-CTG-TAT-G-3′, reverse primer 3′-
TTT-GGC-TGG-AAA-ATA-TAA-CTC-TCG-TA-3′ and
Yakima Yellow-labelled TaqMan probe YY-AAG-CCG-
TCT-TGA-TAA-TCT-TTA-GTA-GTA-CCG-AAG-CTG-
GT-BHQ1).
For all four latex agglutination assays, the interpretative
reading comprised of either a positive, negative or
indeterminate test result. If the agglutination was indeter-
minate, the strain would be excluded from the statistical
analysis. Statistical analysis was performed using McNe-
mar’s test (two-tailed, GraphPad Inc. Software 2005) and
all p-values were calculated versus the DML Staph assay.
Daily practice study
During a 3-month period in our clinical microbiology
laboratory, presumptive identification of staphylococcal
strains was performed by using both the Slidex Staph Plus
and the DML Staph assays. All staphylococcal strains from
cultures of consecutive clinical specimens were handled
according to the laboratories’ routine procedures. Both
agglutination assays were performed by any of the 30
laboratory physicians during daily practice. All isolates were
included based upon the inspection of colony morphology: if
a staphylococcal isolate was suspected, both agglutination
tests were performed in conjunction with the DNAse test,
coagulase test and a cefoxitin disc susceptibility test on a
Mueller-Hinton agar plate (30 μ, cut-off zone 22 mm, Oxoid
Ltd., Basingstoke, United Kingdom) or automated suscepti-
bilitytesting(bioMérieuxVitek,Inc.,Hazelwood,MO,USA).
Strains with a negative Slidex Staph Plus, DML Staph,
DNAse and coagulase test were determined as CNS; strains
with a positive result in all tests were determined as S. aureus.
The determination of MSSA or MRSA was defined by
cefoxitin susceptibility or resistance, respectively. All isolates
with discordant test results of either agglutination assay,
DNAse or coagulase results were retested for DNAse
activity, coagulase activity, the presence of the mecA gene
and S. aureus-specific genomic DNA (PCR) to confirm
identification of the specific strain, analogous to the strain
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Eur J Clin Microbiol Infect Dis (2011) 30:259–264 261study. Interpretation and statistical analysis was performed
analogous to the strain study.
Results
Strain study
In all isolates tested with the DML Staph assay, a clear
interpretational reading of the agglutination could be made (see
Table 2). In contrast, in 0.6, 0.4 and 1.5% of all the strains
tested using the Slidex Staph Plus, Staphaurex Plus or
Pastorex Staph-Plus assays, respectively, the result was
doubtful and no final interpretation could be made. After
excluding the strains with indeterminate test results, the results
of all four assays were statistically analysed. The overall
sensitivity was highest for the DML Staph assay, being
99.2%. Within the MRSA strains subset, the sensitivity of the
DML Staph assay was also the highest (98.8%) compared to
the other assays. However, the sensitivity of the Slidex Staph
Plus assay was highest (100%) among the MSSA strains,
followed closely by the DML Staph assay (99.6%). In the
statistical analysis, only the Staphaurex Plus assay sensitivity
was significantly lower (p=0.0001). In the sub-analysis, this
significantly lower sensitivity could be attributed to a lesser
performance in the MRSA strain subset especially.
The specificity of the DML Staph assay was unremark-
able (100%) for all strains altogether and for MSSA and
MRSA strains specifically. A similar specificity was
calculated for the Slidex Staph Plus and Staphaurex Plus
assays; however, the Pastorex Staph-Plus assay showed a
less than perfect specificity (98.8%).
The DML Staph assay failed to display agglutination in
five S. aureus strains (false-negatives: one MSSA and four
MRSA). Subsequent testing of these strains confirmed the
original identification as either MSSA (DNAse-positive,
coagulase-positive, mecA gene-negative, S. aureus genomic
DNA-positive) or MRSA (DNAse-positive, coagulase-
positive, mecA gene-positive, S. aureus genomic DNA-
positive). Between all four latex assays, only the Pastorex
Staph-Plus assay had shown false-positive reactions: two S.
lugdunensis strains and one S. capitis strain.
Daily practice study
In total, 1,865 staphylococcal strains (883 CNS, 847 MSSA
and 135 MRSA) were tested with both the DML Staph and
the Slidex Staph Plus assays (Table 3). Forty-five strains
(41 CNS, two MSSA and two MRSA) were excluded from
statistical analyses because one or both agglutination tests
were indeterminate. The DML Staph assay was indetermi-
nate in 20 strains (1.1%): 17 CNS, one MSSA and two
MRSA strains. The Slidex Staph Plus assay was indeter-
minate in 36 strains (1.9%): 34 CNS, one MSSA and one
MRSA. In 11 CNS strains, both the DML Staph and the
Slidex Staph Plus assays were indeterminate.
The overall sensitivity of the DML Staph and the Slidex
Staph Plus assays was similar compared to the strain study
results. Similarly, the NPV was comparable for both tests in
both studies. However, in the MRSA strain subset, the
sensitivity of the DML Staph assay was less than that of the
SlidexStaph Plusassay, whereasin the strainstudy, thiswasthe
other way around. The specificity of the Slidex Staph Plus
assaywassignificantlyhigherthanthatoftheDMLStaphassay
(p<0.0005). Similarly, the PPV of the DML Staph assay was
significantly lower than that of the Slidex Staph Plus assay.
The false-positive results in both the DML Staph and the
Slidex Staph Plus assays were mostly found in MRSA
strains, 5/1 (MRSA/MSSA) and 3/0 (MRSA/MSSA),
respectively. In two MRSA strains, both tests produced
false-negative results. The DML Staph and the Slidex Staph
Plus assays produced false-positive results in 36 and 14
CNS strains, respectively, where all 14 CNS strains were
false-positive in both tests.
Remarkably, in 30 CNS strains, the DNAse and
coagulase tests were false-positive (negative S. aureus/
Table 3 Results of the DML Staph assay versus the Slidex Staph Plus assay in the daily practice study. The gold standard determination(CNS,
MSSA, MRSA) of the non-interpretable strains is shown; these strains were excluded from further statistical analysis. The sensitivity,specificity,
PPV and NPV are shown. The p-value was calculated two-tailed using McNemar’s test for the Slidex Staph Plus assay versus the DML Staph
assay
N=1,865 DML Staph Slidex Staph Plus
Non-interpretable strains (%) 17× CNS; 1× MSSA; 2× MRSA (1.1) 34× CNS; 1× MSSA; 1× MRSA (1.9)
n=1,820 All MSSA MRSA All MSSA MRSA
Sensitivity (%) 99.4 99.9 96.2 99.7 100 97.7
Specificity (%) 95.7 95.7 95.7 98.3 98.3 98.3
PPV (%) 96.4 95.9 78.1 98.6 98.4 90.3
NPV (%) 99.3 99.9 99.4 99.6 100 99.6
p-value ––– 0.0005 0.0000 0.0002
Table 3 Results of the DML Staph assay versus the Slidex Staph Plus
assay in the daily practice study. The gold standard determination
(CNS, MSSA, MRSA) of the non-interpretable strains is shown; these
strains were excluded from further statistical analysis. The sensitivity,
specificity, PPVand NPVare shown. The p-value was calculated two-
tailed using McNemar’s test for the Slidex Staph Plus assay versus the
DML Staph assay
262 Eur J Clin Microbiol Infect Dis (2011) 30:259–264mecA PCR), where both the DML Staph and the Slidex
Staph Plus assays gave a true-negative result. In 29 cases,
this CNS was derived from cultures taken from veterinar-
ians as part of MRSA surveillance.
Discussion
In 2001, an international multi-centre evaluation of latex
agglutination tests for the identification of S. aureus was
published by van Griethuysen et al. [5]. In that study, the
Slidex Staph Plus (bioMérieux) assay was compared to the
Staphaurex Plus (Murex Diagnostics) and Pastorex Staph-Plus
(Sanofi Diagnostics Pasteur) assays. In addition to clumping
factor and protein A, all three assays also detect certain surface
antigens: Slidex Staph Plus and Staphaurex Plus detect group-
specific antigens on the S. aureus cell surface, and Pastorex
Staph-Plus detects capsular polysaccharides 5 and 8. In the
strain study, the DML Staph assay (DiaMondiaL) performance
was superior compared to the other three latex agglutination
assays in differentiating S. aureus from CNS, in the same
strain collection as used by van Griethuysen et al. The overall
sensitivity and specificity of the Slidex Staph Plus assay was
comparable; however, in contrast to the DML Staph assay, it
failed to produce a definite result in 0.6% of all isolates. This
leads to additional confirmatory testing and costs.
Twenty-nine CNS strains gave false-positive results in the
van Griethuysen et al. study [5]. It was suggested that
especially S. lugdunensis, S. schleiferi and S. haemolyticus
were prone to false-positive test results. However, in this study,
only three false-positives were found and only when using the
Pastorex Staph-Plus assay. Since the van Griethuysen et al.
study was an international collaboration, only the Dutch subset
of the strain collection originally used was available for this
study and, consequently, the number of false-positives cannot
be compared. Local epidemiology may affect the performance
of diagnostic tests and this should be borne in mind when
translating the results of studies into routine diagnostics.
In the strain study, the detection of MSSA strains was very
accurate in all four assays. The DML Staph assay performed
particularly well in MRSA strains: its sensitivity and
specificity was superior compared to the other three assays.
In the literature, several reports have suggested that the
additional detection of capsular polysaccharides 5 and 8,
similar to the DML Staph assay, could explain the better
performance ofsuchassaysin MRSAstrains [2, 9]. However,
the Pastorex Staph-Plus assay also detects capsular poly-
saccharides 5 and 8, but appeared to be only slightly less
effective than the DML Staph assay: the sensitivity in the
MRSA strain subset was 97.3% versus 98.8%, respectively
(not significant). The Slidex Staph Plus and Staphaurex Plus
assays have also been constructed to detect additional surface
antigens of S. aureus. In the strain study, both assays
performed less well (sensitivity 96.1% and 91.3%) than the
DML Staph assay (98.8%) in detecting MRSA; however,
only for the Staphaurex Plus assay did this reach statistical
significance. The microparticles in the DML Staph assay
were especially engineered to enhance antibody–antigen
complex formation. This may explain the increase in
sensitivity compared to the third-generation assays.
In order to rule out observational bias by performing the
DML Staph assay by a single person, a secondary study was
performed. In this daily practice study, the results of the DML
Staph assay were different to in the strain study. In the former,
the DML Staph assay appeared superior, whereas in the latter,
the Slidex Staph Plus assay performed significantly better. In
the daily practice study, differences between the DML Staph
and the Slidex Staph Plus assays were almost exclusively
attributable to a significant difference in the number of false-
positives: the DML Staph assay displayed positive agglutina-
tion in 36 CNS strains versus 14 in the Slidex Staph Plus
assay.Thisiswhytheseagglutinationassaysshouldalwaysbe
used for presumptive identification only and in combination
with other tests like DNAse and coagulase tests for definite
results. Although the performance of the Slidex Staph Plus
assay appeared superior in the daily practice study, in both
sub-studies, the number of indeterminate results was consid-
erably higher for the Slidex Staph Plus assay. Taking this into
account, in daily practice, the DML Staph and the Slidex
Staph Plus assays have equal performance characteristics.
A remarkable subset of 30 CNS strains was found in the
daily practice study, where both agglutination assays gave
true-negative results in contrast to the DNAse and coagu-
lase tests. All but one of these strains were isolated from
veterinarians during a targeted MRSA surveillance project.
It is known that S. intermedius and S. hyicus strains can
also secrete coagulase during bacterial growth [10].
Furthermore, S. intermedius and S. hyicus are well known
for their pathogenicity in animals but not in humans [11].
Overall, the results of the fourth-generation latex aggluti-
nation assay proved to be comparable to third-generation
assays, both in terms of sensitivity and specificity and ease to
identify S. aureus strains.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
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